Jeffrey Chodakewitz, EVP GMDA – CMO of Vertex Pharmaceuticals (VRTX) Just Sold Shares; Callaway Golf Co (ELY) Has 1.19 Sentiment

Callaway Golf Company, together with its subsidiaries, designs, makes, and sells golf clubs, golf balls, golf bags, and other golf-related accessories in the United States and internationally. The company has market cap of $1.40 billion. It offers drivers, fairway woods, hybrids, irons, wedges, and putters. It has a 7.79 P/E ratio. The firm also accessories, such as packaged sets, golf gloves, golf footwear, golf apparel, travel gear, headwear, towels, umbrellas, eyewear, and other accessories under the Callaway Golf, Odyssey, and Strata brand names.

Jeffrey Chodakewitz, the EVP GMDA – CMO of Vertex Pharmaceuticals Inc Ma made sell of 3,594 shares with an average stock price per share of $161.5 in the ‘s company, that are with a grand total value of $580,304 U.S. Dollars. This is not his first insider trade, in the last 30 days, he sold another 5,415 shares worth $886,823 USD. Jeffrey Chodakewitz now has rights to 52,524 shares or 0.02% of Vertex Pharmaceuticals Inc Ma’s market cap.

Among 30 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 26 have Buy rating, 0 Sell and 4 Hold. Therefore 87% are positive. Vertex Pharmaceuticals has $212.0 highest and $85.0 lowest target. $176.31’s average target is 13.26% above currents $155.67 stock price. Vertex Pharmaceuticals had 94 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has “Perform” rating given on Thursday, February 11 by Oppenheimer. The stock has “Hold” rating by Jefferies on Wednesday, September 9. The firm has “Hold” rating by Vetr given on Monday, August 24. The rating was maintained by J.P. Morgan on Wednesday, July 19 with “Buy”. Jefferies maintained the stock with “Buy” rating in Friday, June 9 report. The firm has “Buy” rating by Oppenheimer given on Sunday, July 9. The firm has “Buy” rating by Cowen & Co given on Tuesday, August 1. On Thursday, February 1 the stock rating was maintained by BMO Capital Markets with “Buy”. Jefferies maintained Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Sunday, August 20 with “Buy” rating. The company was upgraded on Thursday, February 1 by Oppenheimer.

Vertex Pharmaceuticals Incorporated discovers, develops, makes, and commercializes medicines for serious diseases. The company has market cap of $39.42 billion. The firm focuses on developing and commercializing therapies for the treatment of cystic fibrosis and advancing its research and development programs. It has a 149.68 P/E ratio. It markets ORKAMBI (lumacaftor in combination with ivacaftor) for the treatment of patients with CF 12 years of age and older who have two copies (homozygous) of the F508del mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene; and KALYDECO (ivacaftor) for the treatment of patients with CF 2 years of age and older who have the G551D mutation or other specified mutations in their CFTR gene.

The stock decreased 2.26% or $3.6 during the last trading session, reaching $155.67. About 1.81M shares traded or 10.02% up from the average. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 45.69% since February 8, 2017 and is uptrending. It has outperformed by 28.99% the S&P500.

Investors sentiment increased to 1.62 in 2017 Q3. Its up 0.11, from 1.51 in 2017Q2. It improved, as 32 investors sold Vertex Pharmaceuticals Incorporated shares while 151 reduced holdings. 79 funds opened positions while 217 raised stakes. 231.42 million shares or 0.04% more from 231.33 million shares in 2017Q2 were reported. Loring Wolcott And Coolidge Fiduciary Advsrs Llp Ma, a Massachusetts-based fund reported 625 shares. New Jersey-based Princeton Strategies Group Inc Ltd Liability has invested 0.08% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Riverhead Capital Management Ltd Liability Corporation invested in 0.04% or 5,479 shares. Caisse De Depot Et Placement Du Quebec invested in 7,905 shares. Ahl Prtn Llp stated it has 0.05% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Geode Mngmt Limited Liability reported 0.14% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Woodstock Corporation owns 4,319 shares. Moreover, Clearbridge Invs Limited Co has 1.04% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 7.08M shares. Atlantic Tru Group Lc has 0.01% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Nuveen Asset Management Limited Liability invested in 88,535 shares or 0.09% of the stock. Btim Corp invested in 0.01% or 2,183 shares. State Board Of Administration Of Florida Retirement accumulated 0.15% or 368,645 shares. Mirae Asset Ltd invested in 30,808 shares. Waddell And Reed Finance Inc holds 3.60 million shares or 1.22% of its portfolio. Gulf Bank & Trust (Uk) reported 77,592 shares or 0.16% of all its holdings.

Since August 31, 2017, it had 0 buys, and 32 sales for $105.67 million activity. 40,000 shares were sold by Sachdev Amit, worth $5.80 million on Tuesday, October 31. Parini Michael sold $324,976 worth of stock. 3,437 shares valued at $521,198 were sold by Chodakewitz Jeffrey on Monday, October 2. $330,671 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares were sold by SMITH IAN F. 9,883 shares were sold by Silva Paul M, worth $1.71M. 4,250 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares with value of $675,750 were sold by Arbuckle Stuart A. The insider Bhatia Sangeeta N. sold $1.68M.

Ratings analysis reveals 50% of Callaway Golf’s analysts are positive. Out of 2 Wall Street analysts rating Callaway Golf, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $12.0 while the high is $13.0. The stock’s average target of $12.50 is -15.37% below today’s ($14.77) share price. ELY was included in 2 notes of analysts from September 9, 2016. Compass Point initiated the shares of ELY in report on Friday, September 9 with “Neutral” rating. On Tuesday, February 7 the stock rating was maintained by Imperial Capital with “Outperform”.

The stock increased 1.23% or $0.18 during the last trading session, reaching $14.77. About 1.29M shares traded or 49.77% up from the average. Callaway Golf Company (ELY) has risen 39.56% since February 8, 2017 and is uptrending. It has outperformed by 22.86% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 6 sales for $1.63 million activity.

D.C. Capital Advisors Ltd holds 6.2% of its portfolio in Callaway Golf Company for 650,000 shares. Ibis Capital Partners Llp owns 300,000 shares or 4.16% of their US portfolio. Moreover, Bernzott Capital Advisors has 3.72% invested in the company for 1.81 million shares. The New York-based Daruma Capital Management Llc has invested 3.47% in the stock. Grace & White Inc Ny, a New York-based fund reported 673,216 shares.